With federal funding, Gemstone Biotherapeutics is eying development of the next generation of its wound-healing technology.

The Federal Hill startup is developing treatments that enable skin regeneration without scars.

Recently, the company received a $225,000 Small Business and Innovation Research (SBIR) grant from the National Science Foundation. The Phase I grant from the program dubbed “America’s Seed Fund” will help further development of the startup’s technology, which was licensed from Johns Hopkins University, toward commercialization, said Gemstone CEO Emily English.

READ FULL ARTICLE HERE